Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hefei Han Microbiology Technology

Request full access

Microbiome-based live biotherapeutics for chronic diseases

ChinaFounded 2021

About Hefei Han Microbiology Technology

Hefei Han Microbiology Technology Co., Ltd. (iBiome) is a biotechnology firm established in June 2021, specializing in the research and development of innovative therapies derived from the human gut microbiome. The company's core business revolves around creating live biotherapeutic products (LBPs) and microbiome-based drugs to address a range of conditions. It focuses on developing immune-modulatory treatments for metabolic diseases, tumors, inflammatory bowel disease, and autoimmune disorders by targeting the gut-brain axis.

The company was co-founded by Professor Zhu Shu and Tao Wanyin, who serves as the legal representative. The research and development team comprises scientists from prominent institutions such as Yale University, Harvard Medical School, and the University of Science and Technology of China. This team possesses a strong background in gut microbiology and immunology, underpinning the company's 'mechanism-oriented' drug development strategy. Hefei Han Microbiology Technology operates advanced R&D platforms that cover the entire process from strain screening and cultivation to efficacy evaluation and clinical trials.

Financially, the company has secured significant funding to advance its pipeline. In December 2021, it received an undisclosed amount in an angel round from CDG Capital. This was followed by a substantial Pre-A round in November 2023, raising over 100 million RMB, led by CICC Capital. A notable milestone was achieved in May 2025 when its IBOB001 enteric-coated capsule received clinical trial approval from the FDA for diabetes treatment.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
13.7/100
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Nov 2023 $14M $55M CICC ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Hefei Han Microbiology Technology website traffic

Latest recorded traffic for Hefei Han Microbiology Technology is 130 monthly website visits, down 76.4% over the last three months.

Latest monthly visits130 3-month web change-76.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hefei Han Microbiology Technology in its local ecosystem

Live from Dealroom

The Hefei Han Microbiology Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hefei Han Microbiology Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hefei Han Microbiology Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.